The total return for Pfizer Inc. (PFE) stock is +14.76% over the past 12 months vs. +24.34% for the S&P 500. So far it's up +6.70% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +7.22% | (12.95%) | (8.38%) | (2.61%) | +1.80% | +0.71% |
| Total Return CAGR | +14.76% | (7.34%) | (3.54%) | +1.93% | +6.25% | +5.28% |
| Revenue CAGR | (0.40%) | (13.24%) | +8.22% | +2.56% | (0.45%) | +1.05% |
| Net Income CAGR | (5.35%) | (35.71%) | (3.77%) | +0.72% | (0.64%) | (0.37%) |
| EPS CAGR | (4.23%) | (37.58%) | (3.78%) | +1.89% | +1.87% | +1.40% |
| Free Cash Flow CAGR | (2.89%) | (26.76%) | (3.79%) | (3.04%) | (0.31%) | (1.40%) |
| Operating Cash Flow CAGR | (4.83%) | (24.07%) | (3.45%) | (1.85%) | +0.30% | (1.01%) |
| Dividends CAGR | +2.38% | +2.44% | +2.50% | +4.38% | +5.98% | +4.44% |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Pfizer Inc. (PFE)
| Year | Start Value | End Value | PFE Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | 585.05 | 624.25 | +6.70% | +8.38% | (1.68%) |
| 2025 | 581.14 | 585.05 | +0.67% | +17.72% | (17.05%) |
| 2024 | 594.45 | 581.14 | (2.24%) | +24.89% | (27.13%) |
| 2023 | 1011.37 | 594.45 | (41.22%) | +26.19% | (67.41%) |
| 2022 | 1129.07 | 1011.37 | (10.42%) | (18.17%) | +7.75% |
| 2021 | 677.15 | 1129.07 | +66.74% | +28.74% | +38.00% |
| 2020 | 654.60 | 677.15 | +3.44% | +18.37% | (14.93%) |
| 2019 | 701.90 | 654.60 | (6.74%) | +31.22% | (37.96%) |
| 2018 | 561.15 | 701.90 | +25.08% | (4.56%) | +29.64% |
| 2017 | 483.31 | 561.15 | +16.11% | +21.70% | (5.59%) |
